STE.NYSESteris PLC

Form 4: STERIS plc Director Cynthia L. Feldmann Reports Stock Option Grant and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Cynthia L. Feldmann reports the acquisition of stock options and restricted stock units in STERIS plc.

Summary

  • Cynthia L. Feldmann, a director of STERIS plc, reported transactions involving the company's securities on August 8, 2024.
  • Feldmann acquired 1,388 nonqualified stock options with an exercise price of $239.68, exercisable immediately and expiring on August 8, 2034.
  • She also acquired 494 Career Restricted Stock Units, which will be settled in STERIS ordinary shares six months after she ceases to be a director.
  • Following these transactions, Feldmann directly owns 1,388 stock options and 7,641 Career Restricted Stock Units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of stock options and restricted stock units to a director is generally viewed as a positive sign, indicating confidence in the company's future performance. However, it's a routine filing and doesn't necessarily indicate a major shift in the company's prospects.

Positives

  • The acquisition of stock options and restricted stock units by a director signals confidence in the company's future performance.
  • The immediate vesting of the stock options provides an incentive for the director to contribute to the company's success.

Future Outlook

The document does not contain specific forward-looking statements, but the grant of stock options and restricted stock units suggests an expectation of future value creation.

Industry Context

This type of filing is standard for corporate insiders and reflects compensation practices common in publicly traded companies.

Comparison to Industry Standards

  • Stock option and restricted stock unit grants are a common form of executive compensation in publicly traded companies, including those in the healthcare and medical device industries.
  • Companies like Medtronic, Stryker, and Johnson & Johnson also utilize similar equity-based compensation plans to align the interests of their directors and executives with those of shareholders.
  • The vesting schedules and terms of these grants are generally in line with industry standards, designed to incentivize long-term performance and retention.

Stakeholder Impact

  • The grant of stock options and restricted stock units aligns the director's interests with those of the shareholders, incentivizing her to work towards increasing shareholder value.

Key Dates

DateDescription
November 2, 2023Date of Power of Attorney authorization for SEC filings.
08/08/2024Date of the reported transactions: acquisition of stock options and restricted stock units.
08/08/2034Expiration date of the acquired stock options.
08/12/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.